Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2Fe7IDS
via IFTTT